Spreadsheet: 0e1439d6-63c2-4202-a40f-2c40eb3a1ab9
Sheet: Sheet1

genes | occurrence | [NAME] et [NAME]. | [NAME] and Hayward | [NAME]. | pathways
BRAF | 3 | 1 | 1 | 1 | Long term potentiation, ERBB, EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, VEGF, MAPK, Regulation of actin cytoskeleton, Notch
NRAS | 3 | 1 | 1 | 1 | Long term potentiation, ERBB, EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, VEGF, MAPK, Regulation of actin cytoskeleton, GAP junction, Fc epsilon RI-mediated signaling
ADORA1 | 2 | 1 | 1 |  | G protein signaling
CDK5 | 2 | 1 | 1 |  | GTPase activating biopeptides, [NAME] guidance
EGFR | 2 |  | 1 | 1 | ERBB, MAPK, Regulation of actin cytoskeleton, GAP junction, Notch
EPHA3 | 2 | 1 | 1 |  | Angiogenesis, [NAME] guidance
FRS2 | 2 | 1 | 1 |  | Angiogenesis, FGF, Nerve growth factor
FZD8 | 2 | 1 | 1 |  | Cadherin signaling, WNT
GRIN3A | 2 | 1 | 1 |  | Neurotransmittor
[NAME] | 2 | 1 | 1 |  | G protein signaling
MAPK9 | 2 | 1 | 1 |  | ERBB, EGF receptor, Integrin (including [NAME] signaling), MAPK, TGF beta, [NAME] pathway, T and B cell activation, Alzheimer disease (amyloid secretase), FGF, Apoptosis/Tumor necrosis factor, Focal adhesion, Nerve growth factor
SFRP1 | 2 | 1 | 1 |  | Angiogenesis, WNT
WNT2B | 2 | 1 | 1 |  | Angiogenesis, Cadherin signaling, WNT
ACTA2 | 1 |  | 1 |  | Cadherin signaling, Alzheimer disease (presentilin)
ACTG2 | 1 | 1 |  |  | Cadherin signaling, Huntington_disease
ACVR2B | 1 |  | 1 |  | TGF beta
ACVRL1 | 1 | 1 |  |  | TGF beta
[NAME] | 1 |  | 1 |  | G protein signaling, Melanogenesis, GAP junction
ADCY2 | 1 |  | 1 |  | G protein signaling, Melanogenesis, GAP junction
ADORA3 | 1 |  | 1 |  | G protein signaling
ADRA2A | 1 | 1 |  |  | G protein signaling
AMHR2 | 1 | 1 |  |  | TGF beta
AP2A2 | 1 |  | 1 |  | Huntington_disease
ARF1 | 1 |  | 1 |  | Integrin (including [NAME] signaling)
ARPC1A | 1 |  | 1 |  | Inflammation mediated by chemokine and cytokine
ARPC1B | 1 |  | 1 |  | Inflammation mediated by chemokine and cytokine
ARPC4 | 1 |  | 1 |  | Inflammation mediated by chemokine and cytokine
ATP5F1 | 1 |  | 1 |  | Purine metabolism
BCAR1 | 1 |  | 1 |  | Integrin (including [NAME] signaling), Regulation of actin cytoskeleton, Focal adhesion
BCKDHB | 1 |  | 1 |  | [NAME] degradation
BCL9 | 1 |  | 1 |  | WNT
BPGM | 1 | 1 |  |  | Glucolysis and Gluconeogenesis
CAMK2A | 1 | 1 |  |  | Long term potentiation, ERBB, GTPase activating biopeptides, [NAME] signalling, Melanogenesis
CAMK2G | 1 | 1 |  |  | Long term potentiation, ERBB, GTPase activating biopeptides, [NAME] signalling, Melanogenesis
CAPG | 1 | 1 |  |  | FAS signaling
CBL | 1 |  | 1 |  | ERBB, EGF receptor, [NAME] pathway, T and B cell activation, JAK STAT
CCNA1 | 1 | 1 |  |  | Cell cycle
CCND1 | 1 |  | 1 |  | WNT
CDC20 | 1 | 1 |  |  | Cell cycle
CDC26 | 1 | 1 |  |  | Cell cycle
CDH12 | 1 |  | 1 |  | Cadherin signaling
CDH17 | 1 |  | 1 |  | Cadherin signaling
CDH18 | 1 |  | 1 |  | Cadherin signaling
CDH19 | 1 | 1 |  |  | Cadherin signaling, WNT
CDH2 | 1 | 1 |  |  | Cadherin signaling, WNT
CDH4 | 1 | 1 |  |  | Cadherin signaling, WNT
CDH9 | 1 |  | 1 |  | Cadherin signaling
CDKN2B | 1 | 1 |  |  | Cell cycle
CELSR2 | 1 |  | 1 |  | Cadherin signaling
CHRM1 | 1 | 1 |  |  | G protein signaling, [NAME] signalling, Alzheimer disease (amyloid secretase)
CHRM2 | 1 |  | 1 |  | G protein signaling, [NAME] signalling, Alzheimer disease (amyloid secretase)
CHRM4 | 1 |  | 1 |  | G protein signaling, [NAME] signalling, Alzheimer disease (amyloid secretase)
[NAME] | 1 | 1 |  |  | G protein signaling, [NAME] signalling, Alzheimer disease (amyloid secretase)
CLTA | 1 |  | 1 |  | Huntington_disease
CLTB | 1 | 1 |  |  | Huntington_disease
CREB3 | 1 |  | 1 |  | G protein signaling, Melanogenesis, Cell cycle
CREB3L1 | 1 |  | 1 |  | Melanogenesis, Cell cycle
CREB3L2 | 1 |  | 1 |  | Melanogenesis, Cell cycle
CREB3L4 | 1 |  | 1 |  | G protein signaling, Melanogenesis, Cell cycle
CRKL | 1 |  | 1 |  | ERBB, Angiogenesis, Integrin (including [NAME] signaling), MAPK, Regulation of actin cytoskeleton, [NAME] pathway, Focal adhesion, Nerve growth factor
CTNNA3 | 1 |  | 1 |  | Cadherin signaling, Adherens junction, Alzheimer disease (presentilin)
[NAME] | 1 | 1 |  |  | EGF receptor
DRD2 | 1 | 1 |  |  | G protein signaling
DRD3 | 1 |  | 1 |  | G protein signaling, Neurotransmittor
DRD4 | 1 |  | 1 |  | G protein signaling, Neurotransmittor
DRD5 | 1 |  | 1 |  | G protein signaling, Neurotransmittor
DUSP1 | 1 | 1 |  |  | MAPK
DUSP12 | 1 | 1 |  |  | MAPK
[NAME] | 1 | 1 |  |  | MAPK
DUSP8 | 1 |  | 1 |  | MAPK
DVL1 | 1 | 1 |  |  | Angiogenesis, Melanogenesis, WNT
DVL3 | 1 |  | 1 |  | Angiogenesis, Cadherin signaling, WNT
EFNA4 | 1 |  | 1 |  | Axon guidance
EFNB2 | 1 | 1 |  |  | Angiogenesis, [NAME] guidance
EIF4A2 | 1 |  | 1 |  | MTOR (translation factor)
EIF4G1 | 1 |  | 1 |  | MTOR (translation factor)
EN2 | 1 |  | 1 |  | WNT
EPHB2 | 1 | 1 |  |  | Angiogenesis, [NAME] guidance
EPHB3 | 1 |  | 1 |  | Angiogenesis, [NAME] guidance
EPHB6 | 1 | 1 |  |  | Axon guidance
ERBB3 | 1 |  |  | 1 | ERBB, EGF receptor
ERBB4 | 1 |  | 1 |  | ERBB, EGF receptor
FAT2 | 1 |  | 1 |  | Cadherin signaling
FES | 1 | 1 |  |  | Axon guidance
FGF1 | 1 | 1 |  |  | Angiogenesis, MAPK, Regulation of actin cytoskeleton, FGF
FGF14 | 1 | 1 |  |  | MAPK, Regulation of actin cytoskeleton, FGF
FGF3 | 1 |  | 1 |  | MAPK, Regulation of actin cytoskeleton, FGF
FGF4 | 1 |  | 1 |  | MAPK, Regulation of actin cytoskeleton, FGF
FGFR3 | 1 |  | 1 |  | Angiogenesis, MAPK, Regulation of actin cytoskeleton, FGF
FGFR4 | 1 | 1 |  |  | MAPK, Regulation of actin cytoskeleton, FGF
FGR | 1 |  | 1 |  | Inflammation mediated by chemokine and cytokine
FLNC | 1 |  | 1 |  | Integrin (including [NAME] signaling)
FLT4 | 1 |  | 1 |  | VEGF
FOXH1 | 1 | 1 |  |  | TGF beta
FRAT1 | 1 | 1 |  |  | WNT
GAB2 | 1 |  |  | 1 | EGF receptor, PDGF signaling, Fc epsilon RI-mediated signaling
GAPDH | 1 | 1 |  |  | Glucolysis and Gluconeogenesis
GNAI3 | 1 |  | 1 |  | G protein signaling, [NAME] signalling, Neurotransmittor
GNAO1 | 1 | 1 |  |  | G protein signaling, [NAME] signalling
GNB2 | 1 |  | 1 |  | G protein signaling, Inflammation mediated by chemokine and cytokine
GNB3 | 1 | 1 |  |  | G protein signaling, Inflammation mediated by chemokine and cytokine
GNB4 | 1 |  | 1 |  | G protein signaling, Inflammation mediated by chemokine and cytokine
[NAME] | 1 | 1 |  |  | G protein signaling
GPR37 | 1 | 1 |  |  | Parkinson disease
GRIN2B | 1 | 1 |  |  | Long term potentiation, Huntington_disease, Neurotransmittor
GRIN2C | 1 | 1 |  |  | Long term potentiation, Huntington_disease, Calcium signalling, Neurotransmittor
GRM6 | 1 |  | 1 |  | G protein signaling
GRM7 | 1 |  | 1 |  | G protein signaling
GSN | 1 | 1 |  |  | FAS signaling
HDAC1 | 1 | 1 |  |  | Cell cycle
[NAME] | 1 |  | 1 |  | Oestrogen receptor (CARM)
[NAME] | 1 |  | 1 |  | Notch
HRAS | 1 |  | 1 |  | Long term potentiation, ERBB, Natural killer cell mediated cytotoxicity, VEGF, MAPK, Regulation of actin cytoskeleton, G protein signaling, [NAME] pathway, T and B cell activation, GTPase activating biopeptides, Melanogenesis, [NAME] guidance, GAP junction, Focal adhesion, Tight juntion
HSPA6 | 1 | 1 |  |  | Parkinson disease
IKBKB | 1 |  | 1 |  | EGF receptor, MAPK, [NAME] pathway, T and B cell activation, Inflammation mediated by chemokine and cytokine, Apoptosis/Tumor necrosis factor
IL2RB | 1 |  | 1 |  | JAK STAT
IMPDH1 | 1 |  | 1 |  | Purine metabolism
[NAME] | 1 |  | 1 |  | Apoptosis/Tumor necrosis factor
JAK2 | 1 |  | 1 |  | [NAME] signaling, GTPase activating biopeptides, Inflammation mediated by chemokine and cytokine, JAK STAT
KALRN | 1 | 1 |  |  | Huntington_disease
KCNQ2 | 1 | 1 |  |  | Neurotransmittor
[NAME] | 1 | 1 |  |  | TGF beta
LFNG | 1 |  | 1 |  | Notch
MAML1 | 1 |  | 1 |  | Notch
[NAME] | 1 |  | 1 |  | Long term potentiation, ERBB, EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, MAPK, Regulation of actin cytoskeleton, TGF beta, [NAME] pathway, T and B cell activation, GTPase activating biopeptides, Melanogenesis, [NAME] guidance, Alzheimer disease (amyloid secretase), FGF, Inflammation mediated by chemokine and cytokine, Apoptosis/Tumor necrosis factor, GAP junction, Adherens junction, Focal adhesion, Nerve growth factor
MFNG | 1 |  | 1 |  | Notch
MLLT4 | 1 |  | 1 |  | Adherens junction, Alzheimer disease (presentilin)
MMP7 | 1 |  | 1 |  | WNT
NCK1 | 1 |  | 1 |  | ERBB, Angiogenesis, PDGF signaling, T and B cell activation, [NAME] guidance
NCOR2 | 1 |  | 1 |  | Notch, Oestrogen receptor (CARM)
NKD2 | 1 |  | 1 |  | WNT
NOTCH2 | 1 |  | 1 |  | Notch
NR2C2 | 1 |  | 1 |  | MAPK
NTNG1 | 1 |  | 1 |  | Axon guidance
NTNG2 | 1 |  | 1 |  | Axon guidance
OPRL1 | 1 | 1 |  |  | G protein signaling
PAPSS2 | 1 |  | 1 |  | Purine metabolism
PCCB | 1 |  | 1 |  | [NAME] degradation
PCDH15 | 1 |  | 1 |  | Cadherin signaling
PCDH17 | 1 | 1 |  |  | Cadherin signaling, WNT
PCDH9 | 1 | 1 |  |  | Cadherin signaling, WNT
PEBP1 | 1 |  | 1 |  | EGF receptor, FGF
[NAME] | 1 | 1 |  |  | Glucolysis and Gluconeogenesis
PHLDB2 | 1 |  | 1 |  | EGF receptor
PIK3C2B | 1 |  | 1 |  | EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), [NAME] guidance, FGF
PIK3CA | 1 |  | 1 |  | ERBB, EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, VEGF, Regulation of actin cytoskeleton, [NAME] pathway, T and B cell activation, [NAME] guidance, FGF, Inflammation mediated by chemokine and cytokine, Apoptosis/Tumor necrosis factor, JAK STAT, Focal adhesion, Nerve growth factor
PIK3R3 | 1 | 1 |  |  | ERBB, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, VEGF, [NAME] pathway, T and B cell activation
PKN3 | 1 | 1 |  |  | Alzheimer disease (amyloid secretase), Neurotransmittor
PLCB2 | 1 | 1 |  |  | G protein signaling, Inflammation mediated by chemokine and cytokine
PLCG2 | 1 |  | 1 |  | ERBB, EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, T and B cell activation, [NAME] guidance, FGF, Inflammation mediated by chemokine and cytokine
POLR1B | 1 |  | 1 |  | Purine metabolism
POLR2H | 1 |  | 1 |  | Purine metabolism, Transcription factors
POLR2J | 1 |  | 1 |  | Purine metabolism, Transcription factors
POLR2K | 1 |  | 1 |  | Purine metabolism, Transcription factors
POLR2L | 1 |  | 1 |  | Purine metabolism
PPP2R2C | 1 |  | 1 |  | Long term potentiation, TGF beta, FGF, Tight juntion
[NAME] | 1 |  | 1 |  | Transcription factors
PRKAG2 | 1 |  | 1 |  | Transcription factors
PRKAR1B | 1 |  | 1 |  | G protein signaling
PRKCI | 1 |  | 1 |  | EGF receptor, Angiogenesis, G protein signaling, [NAME] pathway, Alzheimer disease (amyloid secretase), FGF, Neurotransmittor, Tight juntion
PRKCZ | 1 | 1 |  |  | EGF receptor, Angiogenesis, VEGF, [NAME] pathway, [NAME] signalling, Alzheimer disease (amyloid secretase), Neurotransmittor
PSMC2 | 1 |  | 1 |  | Ubiquitin proteasome
[NAME] | 1 |  | 1 |  | Ubiquitin proteasome
PSMD2 | 1 |  | 1 |  | Ubiquitin proteasome
PSMD6 | 1 |  | 1 |  | Ubiquitin proteasome
PTPN11 | 1 |  | 1 |  | EGF receptor, Angiogenesis, Natural killer cell mediated cytotoxicity, [NAME] pathway, FGF, JAK STAT, Nerve growth factor
PTPN7 | 1 |  | 1 |  | MAPK, T and B cell activation
PVRL1 | 1 |  | 1 |  | Adherens junction, Alzheimer disease (presentilin)
PYGO2 | 1 |  | 1 |  | WNT
RAB13 | 1 |  | 1 |  | Tight juntion
RAC2 | 1 |  | 1 |  | Integrin (including [NAME] signaling), [NAME] guidance
[NAME] | 1 |  | 1 |  | Long term potentiation, ERBB, EGF receptor, Angiogenesis, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, PDGF signaling, MAPK, Regulation of actin cytoskeleton, [NAME] pathway, T and B cell activation, GTPase activating biopeptides, Melanogenesis, FGF, Inflammation mediated by chemokine and cytokine, GAP junction, Focal adhesion
[NAME] | 1 |  | 1 |  | Long term potentiation, Integrin (including [NAME] signaling), MAPK, G protein signaling, Focal adhesion
RAP1B | 1 |  | 1 |  | Long term potentiation, Integrin (including [NAME] signaling), MAPK, G protein signaling, Focal adhesion
RAPGEF1 | 1 |  | 1 |  | Integrin (including [NAME] signaling), [NAME] pathway, Focal adhesion
RAPGEF3 | 1 |  | 1 |  | Long term potentiation
RASA4 | 1 |  | 1 |  | EGF receptor, PDGF signaling, FGF
RGS10 | 1 | 1 |  |  | G protein signaling, [NAME] signalling
RGS11 | 1 | 1 |  |  | G protein signaling, [NAME] signalling
RGS12 | 1 |  | 1 |  | G protein signaling
RGS14 | 1 | 1 |  |  | G protein signaling, [NAME] signalling
RGS19 | 1 | 1 |  |  | G protein signaling, [NAME] signalling
RHOC | 1 |  | 1 |  | Integrin (including [NAME] signaling), [NAME] guidance
RPL32 | 1 |  | 1 |  | Ribosomes
RPL37 | 1 |  | 1 |  | Ribosomes
RPLP2 | 1 |  | 1 |  | Ribosomes
RPS27 | 1 |  | 1 |  | Ribosomes
SCIN | 1 | 1 |  |  | FAS signaling
SH2B2 | 1 |  | 1 |  | Insulin pathway
SHANK2 | 1 |  | 1 |  | Neurotransmittor
SHC1 | 1 |  | 1 |  | ERBB, Integrin (including [NAME] signaling), Natural killer cell mediated cytotoxicity, VEGF, MAPK, [NAME] pathway, T and B cell activation, GTPase activating biopeptides, Focal adhesion, Nerve growth factor
SMAD9 | 1 | 1 |  |  | TGF beta
SMARCA2 | 1 |  | 1 |  | WNT
SMARCD3 | 1 |  | 1 |  | WNT
SMURF1 | 1 |  | 1 |  | Ubiquitin proteasome
SPIC | 1 |  | 1 |  | Transcription factors
SSTR1 | 1 |  | 1 |  | G protein signaling
SSTR3 | 1 |  | 1 |  | G protein signaling
SSTR4 | 1 |  | 1 |  | G protein signaling
SSTR5 | 1 |  | 1 |  | G protein signaling
STAT2 | 1 |  |  | 1 | EGF receptor, PDGF signaling, JAK STAT
STAT6 | 1 |  |  | 1 | EGF receptor, PDGF signaling, JAK STAT
TAF13 | 1 |  | 1 |  | Transcription factors
TANK | 1 | 1 |  |  | Apoptosis/Tumor necrosis factor
TGFB1 | 1 | 1 |  |  | TGF beta
TGFBR1 | 1 |  | 1 |  | MAPK, TGF beta, [NAME] junction
TH | 1 |  | 1 |  | Parkinson disease
TLL2 | 1 | 1 |  |  | TGF beta
TLN1 | 1 |  | 1 |  | Integrin (including [NAME] signaling)
TNFRSF1B | 1 | 1 |  |  | Apoptosis/Tumor necrosis factor
TRAF1 | 1 | 1 |  |  | Apoptosis/Tumor necrosis factor
TRAF2 | 1 | 1 |  |  | Apoptosis/Tumor necrosis factor
TUBB1 | 1 | 1 |  |  | Cytoskeletal regulation
TUBB2C | 1 | 1 |  |  | Cytoskeletal regulation
UBA3 | 1 | 1 |  |  | Ubiquitin proteasome
UBE2E2 | 1 | 1 |  |  | Ubiquitin proteasome
UBE2J2 | 1 | 1 |  |  | Parkinson disease
UBE2L3 | 1 |  | 1 |  | Parkinson disease, Ubiquitin proteasome
UBE2T | 1 |  | 1 |  | Ubiquitin proteasome
WNT11 | 1 | 1 |  |  | Cadherin signaling, Melanogenesis, WNT
WNT16 | 1 | 1 |  |  | Cadherin signaling, Melanogenesis, WNT
WNT3A | 1 |  | 1 |  | Cadherin signaling, WNT
WNT4 | 1 | 1 |  |  | Cadherin signaling, Melanogenesis, WNT
WNT5B | 1 | 1 |  |  | Angiogenesis, Cadherin signaling, Melanogenesis, WNT
WNT7A | 1 |  | 1 |  | Angiogenesis, Cadherin signaling, WNT
WNT9A | 1 |  | 1 |  | Cadherin signaling, WNT
WWP2 | 1 |  | 1 |  | Ubiquitin proteasome